Who is a candidate for MICS?
The majority of minimally-invasive cardiac surgery is directed to patients with valvular heart disease including aortic, mitral, and tricuspid valve stenosis (narrowin) or regurgitation (leaking). In addition, minimally invasive cardiac surgery can be used for the treatment of atrial fibrillation closure of atrial septal defects and patent foramen ovales, and certain patients requiring coronary artery bypass surgery.
